NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
35 hedge funds and large institutions have $8.63M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
6
Reduced
5
Closed
6
Calls
$66K
Puts
–
Net Calls
+$66K
Net Calls Change
+$84K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$75K |
| 2 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
+$64.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.34K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.43K |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.08K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$615K |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$447K |
| 3 |
Millennium Management
New York
|
-$45.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42K |
| 5 |
VF
Virtu Financial
New York
|
-$25K |
